Product

Company

Clareo Health | Mechanisms of Intradialytic Hypertension

NCT01947673·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Emory University

With

Age

18–80

Sex

ALL

Healthy volunteers

Not accepted

ESRD patients on maintenance hemodialysis for at least 6 months, with increased blood pressure during hemodialysis

drug or alcohol abuse
any serious systemic disease that might influence survival
severe anemia with hgb level \<8 g/dL
clinical evidence of congestive heart failure
ejection fraction below 35%
myocardial infarction or cerebrovascular accident within the past six months
symptomatic heart disease determined by electrocardiogram, stress test, and/or history
treatment with central alpha agonists or monoamine oxidase (MAO) inhibitors
peripheral neuropathy
autonomic dysfunction
pregnancy
surgery within the past 3 months

The record

StatusCompleted

PhaseNo phase

Taking part49

StartedSep 2013

UpdatedJul 15, 2021

Conditions

Where1